Phase II exemestane versus paclitaxel as first-line treatment of patients with metastatic hormone receptor positive breast cancer
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Exemestane (Primary) ; Paclitaxel
- Indications Adenocarcinoma; Breast cancer
- Focus Therapeutic Use
- 19 Jan 2017 New trial record